

( (S (NP-SBJ MedChem Products Inc.)
     (VP said
         (SBAR 0
               (S (NP-SBJ (NP a U.S. District Court)
                          (PP-LOC in
				  (NP Boston)))
                  (VP ruled
                      (SBAR that
                            (S (NP-SBJ (NP a challenge)
                                       (PP by
                                           (NP MedChem))
                                       (PP to
                                           (NP (NP the validity)
                                               (PP of
                                                   (NP (NP a U.S. patent)
                                                       (VP held
                                                           (NP *)
                                                           (PP by
                                                               (NP-LGS Pharmacia Inc.))))))))
                               (VP was 
				   ``
				   (PP-PRD without
					   (NP merit)))))))))
     .
     ''))
( (S (NP-SBJ (NP Pharmacia)
             ,
             (VP based
                 (NP *)
                 (PP-LOC-CLR in
			     (NP (NP Upsala)
				 ,
				 (NP Sweden))))
             ,)
     (VP had
         (VP charged
             (PP-LOC in
		     (NP (NP a lawsuit)
			 (PP against
			     (NP MedChem))))
             (SBAR that
                   (S (NP-SBJ (NP MedChem 's)
                              AMVISC product line)
                      (VP infringes
                          (PP-CLR on
				  (NP the Pharmacia patent)))))))
     .))
( (S (NP-SBJ-1 The patent)
     (VP is
         (ADJP-PRD related
		   (PP to
		       (NP (NP hyaluronic acid)
			   ,
			   (NP (NP a rooster-comb extract)
			       (VP used
				   (NP *)
				   (PP-LOC in
					   (NP eye surgery))))))))
     .))
( (S (PP-LOC In
	     (NP its lawsuit))
     ,
     (NP-SBJ Pharmacia)
     (VP is
         (VP seeking
             (NP (NP unspecified damages)
                 and
                 (NP (NP a preliminary injunction)
                     (SBAR (WHNP-1 0)
			   (S (NP-SBJ *T*-1)
			      (VP to
				  (VP block
				      (NP-2 MedChem)
				      (PP-CLR from
					      (S-NOM (NP-SBJ *-2)
						     (VP selling
							 (NP the AMVISC products))))))))))))
     .))
( (S (NP-SBJ A MedChem spokesman)
     (VP said
         (SBAR 0
               (S (NP-SBJ the products)
                  (VP contribute
                      (NP (NP (NP (QP about a) third)
                              (PP of
                                  (NP (NP MedChem 's)
                                      sales)))
                          and
                          (NP (NP (NP (QP 10 % to 20 %) *U*))
			      (PP of
				  (NP its earnings))))))))
     .))
( (S (PP-TMP In
	     (NP (NP the year)
		 (VP ended
		     (NP-TMP Aug. 31 , 1988))))
     ,
     (NP-SBJ MedChem)
     (VP earned
         (NP (NP (QP $ 2.9 million) *U*)
             , 
	     or
             (NP (NP 72 cents)
                 (NP-ADV a share)))
         ,
         (PP on
             (NP (NP sales)
                 (PP of
                     (NP (QP $ 17.4 million) *U*)))))
     .))
( (S (NP-SBJ MedChem)
     (VP said
         (SBAR 0
               (S (NP-SBJ-1 (NP the court 's)
			    ruling)
                  (VP (VP was
			  (VP issued
			      (NP *-1)
			      (PP as
				  (NP (NP part)
				      (PP of
					  (NP (NP a `` first-phase trial '')
					      (PP-LOC in
						      (NP the patent-infringement proceedings))))))))
		      and
		      (VP concerns
			  (NP (NP only one)
			      (PP of
				  (NP (NP its defenses)
				      (PP-LOC in
					      (NP the case))))))))))
     .))
( (S (NP-SBJ It)
     (VP said
         (SBAR 0
               (S (NP-SBJ it)
                  (VP is
                      (VP considering
			  ``
                          (NP (NP all)
			      (PP of
				  (NP its options))
			      (PP *ICH*-1))
			  (PP-LOC in
				  (NP (NP light)
				      (PP of
					  (NP the decision))))
			  ,
			  (PP-1 including
				(NP a possible appeal)))))))
     .
     ''))
( (S (NP-SBJ The medical-products company)
     (VP added
         (SBAR that
               (S (NP-SBJ-1 it)
                  (VP plans
                      (S (NP-SBJ *-1)
                         (VP to
			     ``
                             (VP assert
                                 (NP (NP its other defenses)
				     ''
				     (PP against
					 (NP (NP Pharmacia 's)
					     lawsuit))
                                     ,
                                     (PP including
                                         (NP the claim
                                             (SBAR that
                                                   (S (NP-SBJ it)
                                                      (VP has n't
                                                          (VP infringed
                                                              (PP-CLR on
								      (NP (NP Pharmacia 's)
									  patent))))))))))))))))
     .))
( (S (NP-SBJ MedChem)
     (VP said
         (SBAR that
               (S (NP-SBJ-1 the court)
                  (VP scheduled
                      (NP a conference)
		      (PP-CLR for
			      (NP next Monday))
		      (PRN -- 
			   (S-PRP (NP-SBJ *-1)
				  (VP to
				      (VP set
					  (NP (NP a date)
					      (PP for
						  (NP (NP proceedings)
						      (PP on
							  (NP (NP (NP Pharmacia 's)
								  motion)
							      (PP for
								  (NP a preliminary injunction)))))))))))))))
     .))
